Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Elisa Di Filippo"'
Autor:
Stefania Arsuffi, Anna Cambianica, Elisa Di Filippo, Diego Ripamonti, Alessandra Tebaldi, Marco Enrico Giovanni Arosio, Claudio Francesco Farina, Marco Rizzi
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 31, Iss , Pp 100360- (2023)
Bacillus Calmette-Guerin (BCG) immunotherapy (i.e., intravesical instillation of live attenuated strain of Mycobacterium bovis) is a standard of care for non-muscle-invasive bladder cancer (NMIBC). The risk of infective adverse events is generally lo
Externí odkaz:
https://doaj.org/article/0785687f963c4097b05149106fae029e
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 21 (2022)
Background: forgiveness is the ability of a given regimen to maintain complete viral suppression despite a documented imperfect adherence. We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide. Methods: drug refills were used to
Externí odkaz:
https://doaj.org/article/08ee674a076945f391fea51ef72fbd26
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 21 (2022)
Background: adherence and forgiveness are key factors for virologic success. We evaluated them for 3TC/DTG. Methods: pharmacy refills were used to calculate the proportion of days covered (PDC). Forgiveness was calculated as the achieved rate of HIV-
Externí odkaz:
https://doaj.org/article/c3c5ba422ca440cea0b38f13df2ff4e4
Autor:
Lucia Taramasso, Antonio Di Biagio, Niccolò Riccardi, Federica Briano, Elisa Di Filippo, Laura Comi, Sara Mora, Mauro Giacomini, Andrea Gori, Franco Maggiolo
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223181 (2019)
Tenofovir alafenamide (TAF) has similar efficacy compared to tenofovir disoproxil fumarate (TDF), but a less favorable effect on lipids. Aim of this retrospective multicentre study was to evaluate the impact on lipids of switching from rilpivirine (R
Externí odkaz:
https://doaj.org/article/1de528fd48e44696a23498bc0c04fad9
Autor:
Elena Raffetti, Maria Concetta Postorino, Francesco Castelli, Salvatore Casari, Filippo Castelnuovo, Franco Maggiolo, Elisa Di Filippo, Alessandro D’Avino, Andrea Gori, Nicoletta Ladisa, Massimo Di Pietro, Laura Sighinolfi, Fabio Zacchi, Carlo Torti
Publikováno v:
BMC Public Health, Vol 16, Iss 1, Pp 1-10 (2016)
Abstract Background We aimed at evaluating frequency and factors associated with late presentation and advanced HIV disease and excess risk of death due to these conditions from 1985 to 2013 among naïve HIV infected patients enrolled in the Italian
Externí odkaz:
https://doaj.org/article/36e825e0f9154243a973cccdb713b6fa
Autor:
Daria Gotti, Elena Raffetti, Laura Albini, Laura Sighinolfi, Franco Maggiolo, Elisa Di Filippo, Nicoletta Ladisa, Gioacchino Angarano, Giuseppe Lapadula, Angelo Pan, Anna Degli Esposti, Massimiliano Fabbiani, Emanuele Focà, Alfredo Scalzini, Francesco Donato, Eugenia Quiros-Roldan, Master Cohort Group
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94768 (2014)
OBJECTIVES: We studied survival and associated risk factors in an Italian nationwide cohort of HIV-infected individuals after an AIDS-defining cancer (ADC) or non-AIDS-defining cancer (NADC) diagnosis in the modern cART era. METHODS: Multi-center, re
Externí odkaz:
https://doaj.org/article/0d4a9d45f05b49a085676d3e41d5126c
Autor:
Marco Rizzi, Franco Maggiolo, Nicola Gianotti, Silvia Nozza, Laura Galli, Elisa Di Filippo, Laura Fumagalli, Daniela Valenti, Antonella Castagna, Laura Comi
Publikováno v:
Antiviral Therapy. 26:51-57
Background Primary analysis at 24 weeks showed that switching to rilpivirine plus darunavir/cobicistat was non-inferior to continuing a standard three-drug antiretroviral regimen in virologically suppressed people with HIV. We present efficacy and sa
Publikováno v:
AIDS. 32:623-628
OBJECTIVE Control HIV replication requires continuous combined antiretroviral therapy (cART) as discontinuation of cART results in a rapid viral rebound. However, a few individuals exist who took cART for several years and did not show the expected v
Publikováno v:
Journal of Immunological Sciences. 2:60-64
Introduction: The use of combination antiretroviral therapy (cART) containing three active drugs from at least two different classes is the standard of care for HIV treatment worldwide. The availability of newer drugs with improved potency and tolera
Autor:
Elisa Di Filippo, Giorgio L Colombo, Sergio Di Matteo, Daniela Valsecchi, Laura Comi, Annapaola Callegaro, Marco Rizzi, Franco Maggiolo
Publikováno v:
Pragmatic and Observational Research
Franco Maggiolo,1 Elisa Di Filippo,1 Laura Comi,1 Annapaola Callegaro,2 Giorgio L Colombo,3,4 Sergio Di Matteo,4 Daniela Valsecchi,5 Marco Rizzi1 1USC of Infectious Diseases, 2USC Microbiology and Virology, 3Department of Drug Sciences, University of